Literature DB >> 3258472

Cause of death in hemophilia A patients in the United States from 1968 to 1979.

D L Aronson1.   

Abstract

Death data on 949 hemophiliacs for the years 1968-1979 have been analyzed. The median age at death has increased from 33 to 55 years. There was no evidence of new diseases caused by the more intensive therapy during this time interval. The leading infectious disease was hepatitis, accounting for eight deaths. Only one acute hepatitis death was listed after 1974, when sensitive tests for hepatitis B antigen screening of plasma were implemented. Cirrhosis was a primary or associated cause of death in 76 cases (8%) and pneumonia was a primary or associated cause of death in 62 deaths (6.5%). The types of malignancies in hemophiliacs were similar to those in the male US population with no evidence of excessive retrovirus malignancies prior to infection with HIV-1.

Entities:  

Mesh:

Year:  1988        PMID: 3258472     DOI: 10.1002/ajh.2830270103

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

Review 1.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  Some characteristics of aggregates of IgG and plasma proteins in heat-treated factor VIII concentrates.

Authors:  C Wadsworth; L A Hanson; H Kjellman; T Söderström; M Blombäck
Journal:  Blut       Date:  1989-03

3.  Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan.

Authors:  M Yoshikawa; H Fukui; H Kojima; H Yoshiji; T Sakamoto; H Imazu; T Nakanani; Y Matsumura; S Kuriyama; J Yamao
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

4.  Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A.

Authors:  C D Porada; C Sanada; C R Long; J A Wood; J Desai; N Frederick; L Millsap; C Bormann; S L Menges; C Hanna; G Flores-Foxworth; T Shin; M E Westhusin; W Liu; H Glimp; E D Zanjani; J N Lozier; V Pliska; G Stranzinger; H Joerg; D C Kraemer; G Almeida-Porada
Journal:  J Thromb Haemost       Date:  2009-11-23       Impact factor: 5.824

5.  Interferon alfa for chronic hepatitis C in haemophiliacs.

Authors:  M Makris; F E Preston; D R Triger; J C Underwood; L Westlake; M I Adelman
Journal:  Gut       Date:  1993       Impact factor: 23.059

6.  Factor VIII and coronary heart disease.

Authors:  F R Rosendaal
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

7.  Prevalence and risk factors for hypertension in hemophilia.

Authors:  Annette von Drygalski; Nicholas A Kolaitis; Ricki Bettencourt; Jaclyn Bergstrom; R Kruse-Jarres; Doris V Quon; Christina Wassel; Ming C Li; Jill Waalen; Darlene J Elias; Laurent O Mosnier; Matthew Allison
Journal:  Hypertension       Date:  2013-04-29       Impact factor: 10.190

8.  AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease.

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

9.  Intramural Haemorrhage and Haematoma as the Cause of Ileus of the Small Intestine in a Haemophiliac.

Authors:  Mirela Delibegovic; Admira Alispahic; Jasmina Gazija; Zlatan Mehmedovic; Majda Mehmedovic
Journal:  Med Arch       Date:  2015-06-10

Review 10.  Five myths about AIDS that have misdirected research and treatment.

Authors:  R S Root-Bernstein
Journal:  Genetica       Date:  1995       Impact factor: 1.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.